Saturday, October 3, 2026

Wall Street Banks Deploy $130B Into Private Credit as Traditional Lending Shrinks

Goldman Sachs and Citigroup are shifting from traditional banking to alternative assets through $105B in private credit partnerships and strategic acquisitions. The pivot follows $25B in divestments including Citi's Russia exit and Goldman's Polish unit sale, reflecting margin pressure from low interest rates and tighter capital requirements facing global banks.

Wall Street Banks Deploy $130B Into Private Credit as Traditional Lending Shrinks
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Citigroup formed $105B in private credit partnerships with Apollo, BlackRock, and Carlyle between June 2024 and September 2025, while Goldman Sachs acquired two alternative investment firms in late 2025. The moves follow $25B in combined divestments as Wall Street banks retreat from traditional markets facing thin margins.

Goldman bought Industry Ventures in January 2026 and Innovator Capital Management in December 2025 after selling its Polish TFI unit to ING in November 2025. The bank raised dividends 12.5% in January 2026 and 33.3% in July 2025, with shares up 20.5% over six months.

Citigroup exited Russia in February 2026 by selling AO Citibank and offloaded equity stakes in Grupo Financiero Banamex the same month. The Russia withdrawal continues Western banks' retreat from the market since 2022. Banamex sales unwind Mexican retail operations Citi acquired in 2001.

Citi's partnerships include a $25B private credit platform with Apollo from September 2024, an $80B customized portfolio offering with BlackRock in September 2025, and asset-based lending with Carlyle from June 2025. BlackRock's deal provides access to Aladdin risk management technology for high-net-worth client portfolios.

JPMorgan consolidated U.S. consumer credit by acquiring Apple's credit card program in January 2026 and General Motors' program in September 2025. The takeovers signal concentration in retail banking as competitors pivot to alternatives.

Private credit partnerships let banks earn fees without holding loans on balance sheets, improving return on equity under Basel III capital requirements. Asset-based lending and structured products offer higher margins than traditional corporate loans in low-rate environments.

Goldman's acquisitions complement its $2.5T asset management division. Industry Ventures specializes in secondary venture investments, while Innovator focuses on defined outcome ETFs serving wealth management clients without branch network overhead.

The restructuring wave includes Citigroup's 20,000 job cuts announced in January 2024. Banks across North America and Europe face similar pressure to reduce costs while shifting capital to higher-margin alternative investments.


Sources:
1 Yahoo Finance, "FutureGen Industries Announces Open Market Investments" (March 23, 2026)
2 Globe Newswire, "ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Apollo Global Management, Inc. Investors to Secure C" (March 21, 2026)
3 Yahoo Finance, "Buying A Home Just Got Cheaper: FHFA Eases Insurance Rules, Cuts Costs For Borrowers" (March 22, 2026)
4 Yahoo Finance, "Mortgage Rates Hit Three-Month High as Iran War Rattles Spring Housing Market" (March 22, 2026)
5 Yahoo Finance, "Is JPMorgan Chase & Co. (JPM) A Good Stock To Buy Now?" (March 16, 2026)

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com